|
PDP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.004600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.261500E-02 |
| Normal-vs-Stage2 |
2.235400E-01 |
| Normal-vs-Stage3 |
5.487600E-01 |
| Normal-vs-Stage4 |
5.98039999999411E-05 |
| Stage1-vs-Stage2 |
8.471800E-01 |
| Stage1-vs-Stage3 |
2.766400E-01 |
| Stage1-vs-Stage4 |
1.31199999975351E-07 |
| Stage2-vs-Stage3 |
5.101000E-01 |
| Stage2-vs-Stage4 |
5.980100E-04 |
| Stage3-vs-Stage4 |
4.175000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.529880E-02 |
| Normal-vs-AfricanAmerican |
1.343010E-01 |
| Normal-vs-Asian |
1.942840E-01 |
| Caucasian-vs-AfricanAmerican |
7.314800E-01 |
| Caucasian-vs-Asian |
2.468600E-01 |
| AfricanAmerican-vs-Asian |
3.781000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.185560E-01 |
| Normal-vs-Female |
1.561410E-03 |
| Male-vs-Female |
2.328100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.941000E-01 |
| Normal-vs-Extreme_Weight |
3.734600E-01 |
| Normal-vs-Obese |
6.978000E-02 |
| Normal-vs-Extreme_Obese |
3.406600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.841800E-01 |
| Normal_Weight-vs-Obese |
7.192400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.182400E-01 |
| Extreme_Weight-vs-Obese |
2.488000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.332000E-01 |
| Obese-vs-Extreme_Obese |
9.792800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.786000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.427800E-02 |
| Normal-vs-Age(61-80Yrs) |
6.349700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.006230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.022800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.430000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.275600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.773400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.458000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.336400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.167600E-02 |
| Normal-VS-Type2 PRCC |
1.935570E-02 |
| Normal-VS-KIRP CIMP |
9.961900E-04 |
| Normal-VS-Unclassified PRCC |
1.210450E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.205800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.33840000000752E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.662200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.02700000000644E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.711600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.415320E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.039400E-01 |
| Normal-vs-N1 |
4.405800E-01 |
| Normal-vs-N2 |
3.956800E-01 |
| N0-vs-N1 |
2.047600E-01 |
| N0-vs-N2 |
2.634200E-01 |
| N1-vs-N2 |
3.064600E-01 |
|
|
